NASDAQ · Biotechnology

ACTU (ACTU) Stock

$1.09 -5.22% NASDAQ: ACTU Healthcare

Valuation

MetricValue
Price$1.09
Market Cap$26.08M
P/E Ratio-2.73
P/B Ratio8.57
P/S Ratio0.00
EPS (TTM)$-1.06
52-Week High$11.99
52-Week Low$1.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-275.00%
ROA-157.14%
ROCE-275.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.11
Current Ratio2.33

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$-20.0M$-25.0M$-25.0M$-22.0M
Net Profit$-20.0M$-25.0M$-27.0M$-22.0M
EPS$-1.34$-1.65$-3.26$-1.06
Op Margin————

Balance Sheet (USD)

Metric2022202320242025
Total Assets$20.0M$3.0M$9.0M$14.0M
Total Liabilities$6.0M$103.0M$9.0M$6.0M
Cash$20.0M$3.0M$9.0M$13.0M
Borrowings$0$0$0$0

Latest News

Actuate Therapeutics Says Elraglusib to be Evaluated in Phase 1/2 Trial to Find Treatments for Pediatric Neuroblastoma MT Newswires · Jun 9, 2026 Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma GlobeNewswire · Jun 9, 2026 Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer GlobeNewswire · Jun 1, 2026 Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program GlobeNewswire · May 11, 2026 Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors GlobeNewswire · May 6, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow$-18.0M$-22.0M$-22.0M$-19.0M
Investing Cash Flow$0$0$0$0
Financing Cash Flow$0$0$-2.0M$0
Net Cash Flow$1.0M$-17.0M$6.0M$5.0M
Free Cash Flow$-18.0M$-22.0M$-22.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-34.02%
Quick Ratio1.80
Interest Coverage—
Return 1Y-71.86%
Return 3Y—
Return 5Y—

Ownership

Insiders Held14.84%
Institutions Held58.20%
Institutions Float Held68.34%
Institutional HolderSharesReport Date
Bios Capital Management, LP 10,049,9962026-03-31
Voss Capital, LP1,725,0002026-03-31
Blackrock Inc.427,1532026-03-31
Vanguard Capital Management LLC400,5292026-03-31
Geode Capital Management, LLC228,3312026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALEC $1.52 +0.33% -1.58 $168.20M 0.00%
APLTApplied Therapeutics, Inc. $0.10 +0.00% -0.24 $14.86M 0.00%
ELTXElicio Therapeutics, Inc. $3.01 +0.17% -1.27 $57.29M 0.00%
MCRB $4.65 -3.12% 11.97 $45.03M 0.00%
MOLNMolecular Partners AG $3.91 -2.25% -2.08 $146.67M 0.00%

About ACTU

ACTU is led by CEO Daniel Schmitt, employs 10 people, headquartered in US, publicly traded since 2024.

ACTU stock trades at $1.09 with a market capitalization of $26.08M. The stock is valued at a price-to-earnings (P/E) ratio of -2.73, price-to-book of 8.57, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.09 and $11.99, and currently trades 90.9% below its 52-week high.

On profitability, ACTU generates a return on equity (ROE) of -275.00%, return on capital employed of -275.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides